Use of umbilical cord blood in the treatment of premature birth complications

Details for Australian Patent Application No. 2008325142 (hide)

Owner Anthrogenesis Corporation

Inventors Hariri, Robert J.; Johnson, Kristine Erikson; Heidaran, Mohammad A.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008325142

PCT Pub. Number WO2009/061447

Priority 61/002,375 07.11.07 US

Filing date 7 November 2008

Wipo publication date 14 May 2009

International Classifications

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61K 35/18 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Erythrocytes

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/061447 Priority application(s): WO2009/061447

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008325148-Solubilized thiazolopyridines

2008325141-Methods of administering N- (5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-m orpholin4-yl-ethoxy)imidazo[2,1-b][1,3]benzothi azol-2-yl]phenyl}urea to treat proliferative disease